IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
Q2 2022 vs. Q1 2022
How the institutions holding IMMUTEP Ltd changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 23 | 22 | −1 |
| Shares | 5.24M | 5.54M | +295.8K (+5.6%) |
| Value | $14.4M | $11.2M | −$3.12M (−21.7%) |
New holders (3)
Institutions that held IMMUTEP Ltd at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Trellus Management Company, LLC | 100,950 | $205.0K | 0.29% |
| Tower Research Capital LLC (TRC) | 9,713 | $20.0K | 0.00% |
| Group One Trading, L.P. | 6,447 | $13.0K | 0.00% |
Sold out (4)
Institutions that held IMMUTEP Ltd at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Alps Advisors Inc | 89,102 | $244.0K |
| Bluefin Capital Management, LLC | 25,000 | $69.0K |
| JustInvest LLC | 11,769 | $32.0K |
| UBS Group AG | 6,456 | $18.0K |